Follow
Nadezhda Orlova
Nadezhda Orlova
Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences
Verified email at biengi.ac.ru - Homepage
Title
Cited by
Cited by
Year
Blood clotting factor VIII: from evolution to therapy
NA Orlova, SV Kovnir, II Vorobiev, AG Gabibov, AI Vorobiev
Acta Naturae (англоязычная версия) 5 (2 (17)), 19-39, 2013
942013
Strategies for induction of catalytic antibodies toward HIV-1 glycoprotein gp120 in autoimmune prone mice
OM Durova, II Vorobiev, IV Smirnov, AV Reshetnyak, GB Telegin, ...
Molecular immunology 47 (1), 87-95, 2009
652009
Coagulation factor IX for hemophilia B therapy
NA Orlova, SV Kovnir, II Vorobiev, AG Gabibov
Acta Naturae (англоязычная версия) 4 (2 (13)), 62-73, 2012
502012
High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector
MV Sinegubova, NA Orlova, SV Kovnir, LK Dayanova, II Vorobiev
PLoS One 16 (2), e0242890, 2021
352021
Improved elongation factor-1 alpha-based vectors for stable high-level expression of heterologous proteins in Chinese hamster ovary cells
NA Orlova, SV Kovnir, JA Hodak, II Vorobiev, AG Gabibov, KG Skryabin
BMC biotechnology 14, 1-12, 2014
352014
A highly productive CHO cell line secreting human blood clotting factor IX
SV Kovnir, NA Orlova, MI Shakhparonov, KG Skryabin, AG Gabibov, ...
Acta Naturae (англоязычная версия) 10 (1 (36)), 51-65, 2018
222018
High-level expression of biologically active human follicle stimulating hormone in the Chinese hamster ovary cell line by a pair of tricistronic and monocistronic vectors
NA Orlova, SV Kovnir, YA Khodak, MA Polzikov, VA Nikitina, KG Skryabin, ...
PLoS One 14 (7), e0219434, 2019
212019
New infestin-4 mutants with increased selectivity against factor XIIa
VN Kolyadko, SV Lushchekina, TA Vuimo, SS Surov, RA Ovsepyan, ...
PLoS One 10 (12), e0144940, 2015
202015
Chemical polysialylation: design of conjugated human oxyntomodulin with a prolonged anorexic effect in vivo
I Vorobiev, V Matskevich, S Kovnir, N Orlova, V Knorre, S Jain, D Genkin, ...
Biochimie 95 (2), 264-270, 2013
172013
Fast and accurate surrogate virus neutralization test based on antibody-mediated blocking of the interaction of ACE2 and SARS-CoV-2 spike protein RBD
DE Kolesov, MV Sinegubova, LK Dayanova, IV Dolzhikova, II Vorobiev, ...
Diagnostics 12 (2), 393, 2022
132022
Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system
NA Orlova, SV Kovnir, AG Gabibov, II Vorobiev
BMC biotechnology 17, 1-15, 2017
132017
Фактор свертывания крови VIII–от эволюции к терапии
НА Орлова, СВ Ковнир, ИИ Воробьев, АИ Воробьев
Acta Naturae (русскоязычная версия) 5 (2 (17)), 19-39, 2013
92013
Stable expression of recombinant factor VIII in CHO cells using methotrexate-driven transgene amplification
NA Orlova, SV Kovnir, II Vorobiev, AS Yuriev, AG Gabibov, AI Vorobiev
Acta Naturae (англоязычная версия) 4 (1 (12)), 93-100, 2012
92012
Targeted Knockout of the dhfr, glul, bak1, and bax Genes by the Multiplex Genome Editing in CHO Cells
NA Orlova, LK Dayanova, EA Gayamova, MV Sinegubova, SV Kovnir, ...
Doklady Biochemistry and Biophysics 502 (1), 40-44, 2022
62022
Antigenic properties of the SARS-CoV-2 nucleoprotein are altered by the RNA admixture
DE Kolesov, MV Sinegubova, IV Safenkova, II Vorobiev, NA Orlova
PeerJ 10, e12751, 2022
62022
Составы растворов биологически активного рекомбинантного фолликулостимулирующего гормона человека
ИИ Воробьев, СВ Ковнир, НА Орлова, ЮА Ходак, МА Ползиков
Разработка и регистрация лекарственных средств, 122-126, 2015
62015
Фактор свертывания крови IX для терапии гемофилии В
НА Орлова, СВ Ковнир, ИИ Воробьев, АГ Габибов
Acta Naturae (русскоязычная версия) 4 (2), 62-75, 2012
52012
A modular assembly cloning technique (aided by the BIOF software tool) for seamless and error-free assembly of long DNA fragments
NA Orlova, AV Orlov, II Vorobiev
BMC Research Notes 5, 1-7, 2012
42012
ШТАММ ГИБРИДНЫХ КУЛЬТИВИРУЕМЫХ КЛЕТОК MUS MUSCULUS-ПРОДУЦЕНТ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ, СПЕЦИФИЧНЫХ К ПРОТЕИНУ С ЧЕЛОВЕКА (ВАРИАНТЫ)
НА Орлова, СВ Ковнир, ИИ Воробьев
42012
Purification Process of a Recombinant Human Follicle Stimulating Hormone Biosimilar (Primapur®) to Yield a Pharmaceutical Product with High Batch-to-Batch …
M Sinegubova, I Vorobiev, A Klishin, D Eremin, N Orlova, N Orlova, ...
Pharmaceutics 14 (1), 96, 2022
32022
The system can't perform the operation now. Try again later.
Articles 1–20